Shield MCD Test Gets Breakthrough Device Designation
Guardant Health’s Shield MCD test has received FDA Breakthrough Device designation for its ability to detect multiple cancer types.
Read MorePosted by Chris Wolski | Jun 4, 2025 | Cancer |
Guardant Health’s Shield MCD test has received FDA Breakthrough Device designation for its ability to detect multiple cancer types.
Read MorePosted by Chris Wolski | Jun 4, 2025 | Mass Spectrometry Instruments |
Thermo Fisher Scientific unveiled advanced mass spectrometry instruments—Orbitrap Astral Zoom MS and Orbitrap Excedion Pro MS.
Read MorePosted by Chris Wolski | Jun 3, 2025 | Molecular Diagnostics |
Seer, Inc. and Korea University have launched a groundbreaking, large-scale proteomics study using the Proteograph Platform.
Read MorePosted by Chris Wolski | May 30, 2025 | POC Instruments |
Researchers have developed a new bioluminescence-based diagnostic tool that offers virus detection in complex biological samples.
Read MorePosted by Chris Wolski | May 29, 2025 | Breast |
SAGA Diagnostics has launched Pathlight, a groundbreaking multi-cancer blood test for ultra-sensitive detection of MRD.
Read More